Identification of a defined linear epitope in the OspA protein of the Lyme disease spirochetes that elicits bactericidal antibody responses: Implications for vaccine development
Abstract The lipoprotein OspA is produced by the Lyme disease spirochetes primarily in unfed ticks. OspA production is down-regulated by the blood meal and it is not produced in mammals except for possible transient production during late stage infection in patients with Lyme arthritis. Vaccination...
Saved in:
Published in | Vaccine Vol. 35; no. 24; pp. 3178 - 3185 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
Netherlands
Elsevier Ltd
31.05.2017
Elsevier Limited |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Abstract The lipoprotein OspA is produced by the Lyme disease spirochetes primarily in unfed ticks. OspA production is down-regulated by the blood meal and it is not produced in mammals except for possible transient production during late stage infection in patients with Lyme arthritis. Vaccination with OspA elicits antibody (Ab) that can target spirochetes in the tick midgut during feeding and inhibit transmission to mammals. OspA was the primary component of the human LYMErix™ vaccine. LYMErix™ was available from 1998 to 2002 but then pulled from the market due to declining sales as a result of unsubstantiated concerns about vaccination induced adverse events and poor efficacy. It was postulated that a segment of OspA that shares sequence similarity with a region in human LFA-1 and may trigger putative autoimmune events. While evidence supporting such a link has not been demonstrated, most efforts to move forward with OspA as a vaccine component have sought to eliminate this region of concern. Here we identify an OspA linear epitope localized within OspA amino acid residues 221–240 (OspA221–240 ) that lacks the OspA region suggested to elicit autoimmunity. A peptide consisting of residues 221–240 was immunogenic in mice. Ab raised against OspA221–240 peptide surface labeled B. burgdorferi in IFAs and displayed potent Ab mediated-complement dependent bactericidal activity. BLAST analyses identified several variants of OspA221–240 and a closely related sequence in OspB. It is our hypothesis that integration of the OspA221–240 epitope into a multivalent-OspC based chimeric epitope based vaccine antigen (chimeritope) could result in a subunit vaccine that protects against Lyme disease through synergistic mechanisms. |
---|---|
AbstractList | The lipoprotein OspA is produced by the Lyme disease spirochetes primarily in unfed ticks. OspA production is down-regulated by the blood meal and it is not produced in mammals except for possible transient production during late stage infection in patients with Lyme arthritis. Vaccination with OspA elicits antibody (Ab) that can target spirochetes in the tick midgut during feeding and inhibit transmission to mammals. OspA was the primary component of the human LYMErix™ vaccine. LYMErix™ was available from 1998 to 2002 but then pulled from the market due to declining sales as a result of unsubstantiated concerns about vaccination induced adverse events and poor efficacy. It was postulated that a segment of OspA that shares sequence similarity with a region in human LFA-1 and may trigger putative autoimmune events. While evidence supporting such a link has not been demonstrated, most efforts to move forward with OspA as a vaccine component have sought to eliminate this region of concern. Here we identify an OspA linear epitope localized within OspA amino acid residues 221-240 (OspA221-240) that lacks the OspA region suggested to elicit autoimmunity. A peptide consisting of residues 221-240 was immunogenic in mice. Ab raised against OspA221-240peptide surface labeledB. burgdorferiin IFAs and displayed potent Ab mediated-complement dependent bactericidal activity. BLAST analyses identified several variants of OspA221-240and a closely related sequence in OspB. It is our hypothesis that integration of the OspA221-240epitope into a multivalent-OspC based chimeric epitope based vaccine antigen (chimeritope) could result in a subunit vaccine that protects against Lyme disease through synergistic mechanisms. The lipoprotein OspA is produced by the Lyme disease spirochetes primarily in unfed ticks. OspA production is down-regulated by the blood meal and it is not produced in mammals except for possible transient production during late stage infection in patients with Lyme arthritis. Vaccination with OspA elicits antibody (Ab) that can target spirochetes in the tick midgut during feeding and inhibit transmission to mammals. OspA was the primary component of the human LYMErix ™ vaccine. LYMErix ™ was available from 1998 to 2002 but then pulled from the market due to declining sales as a result of unsubstantiated concerns about vaccination induced adverse events and poor efficacy. It was postulated that a segment of OspA that shares sequence similarity with a region in human LFA-1 and may trigger putative autoimmune events. While evidence supporting such a link has not been demonstrated, most efforts to move forward with OspA as a vaccine component have sought to eliminate this region of concern. Here we identify an OspA linear epitope localized within OspA amino acid residues 221–240 (OspA 221–240 ) that lacks the OspA region suggested to elicit autoimmunity. A peptide consisting of residues 221–240 was immunogenic in mice. Ab raised against OspA 221–240 peptide surface labeled B. burgdorferi in IFAs and displayed potent Ab mediated-complement dependent bactericidal activity. BLAST analyses identified several variants of OspA 221–240 and a closely related sequence in OspB. It is our hypothesis that integration of the OspA 221–240 epitope into a multivalent-OspC based chimeric epitope based vaccine antigen (chimeritope) could result in a subunit vaccine that protects against Lyme disease through synergistic mechanisms. Abstract The lipoprotein OspA is produced by the Lyme disease spirochetes primarily in unfed ticks. OspA production is down-regulated by the blood meal and it is not produced in mammals except for possible transient production during late stage infection in patients with Lyme arthritis. Vaccination with OspA elicits antibody (Ab) that can target spirochetes in the tick midgut during feeding and inhibit transmission to mammals. OspA was the primary component of the human LYMErix™ vaccine. LYMErix™ was available from 1998 to 2002 but then pulled from the market due to declining sales as a result of unsubstantiated concerns about vaccination induced adverse events and poor efficacy. It was postulated that a segment of OspA that shares sequence similarity with a region in human LFA-1 and may trigger putative autoimmune events. While evidence supporting such a link has not been demonstrated, most efforts to move forward with OspA as a vaccine component have sought to eliminate this region of concern. Here we identify an OspA linear epitope localized within OspA amino acid residues 221–240 (OspA221–240 ) that lacks the OspA region suggested to elicit autoimmunity. A peptide consisting of residues 221–240 was immunogenic in mice. Ab raised against OspA221–240 peptide surface labeled B. burgdorferi in IFAs and displayed potent Ab mediated-complement dependent bactericidal activity. BLAST analyses identified several variants of OspA221–240 and a closely related sequence in OspB. It is our hypothesis that integration of the OspA221–240 epitope into a multivalent-OspC based chimeric epitope based vaccine antigen (chimeritope) could result in a subunit vaccine that protects against Lyme disease through synergistic mechanisms. The lipoprotein OspA is produced by the Lyme disease spirochetes primarily in unfed ticks. OspA production is down-regulated by the blood meal and it is not produced in mammals except for possible transient production during late stage infection in patients with Lyme arthritis. Vaccination with OspA elicits antibody (Ab) that can target spirochetes in the tick midgut during feeding and inhibit transmission to mammals. OspA was the primary component of the human LYMErix™ vaccine. LYMErix™ was available from 1998 to 2002 but then pulled from the market due to declining sales as a result of unsubstantiated concerns about vaccination induced adverse events and poor efficacy. It was postulated that a segment of OspA that shares sequence similarity with a region in human LFA-1 and may trigger putative autoimmune events. While evidence supporting such a link has not been demonstrated, most efforts to move forward with OspA as a vaccine component have sought to eliminate this region of concern. Here we identify an OspA linear epitope localized within OspA amino acid residues 221–240 (OspA221–240) that lacks the OspA region suggested to elicit autoimmunity. A peptide consisting of residues 221–240 was immunogenic in mice. Ab raised against OspA221–240 peptide surface labeled B. burgdorferi in IFAs and displayed potent Ab mediated-complement dependent bactericidal activity. BLAST analyses identified several variants of OspA221–240 and a closely related sequence in OspB. It is our hypothesis that integration of the OspA221–240 epitope into a multivalent-OspC based chimeric epitope based vaccine antigen (chimeritope) could result in a subunit vaccine that protects against Lyme disease through synergistic mechanisms. The lipoprotein OspA is produced by the Lyme disease spirochetes primarily in unfed ticks. OspA production is down-regulated by the blood meal and it is not produced in mammals except for possible transient production during late stage infection in patients with Lyme arthritis. Vaccination with OspA elicits antibody (Ab) that can target spirochetes in the tick midgut during feeding and inhibit transmission to mammals. OspA was the primary component of the human LYMErix™ vaccine. LYMErix™ was available from 1998 to 2002 but then pulled from the market due to declining sales as a result of unsubstantiated concerns about vaccination induced adverse events and poor efficacy. It was postulated that a segment of OspA that shares sequence similarity with a region in human LFA-1 and may trigger putative autoimmune events. While evidence supporting such a link has not been demonstrated, most efforts to move forward with OspA as a vaccine component have sought to eliminate this region of concern. Here we identify an OspA linear epitope localized within OspA amino acid residues 221-240 (OspA ) that lacks the OspA region suggested to elicit autoimmunity. A peptide consisting of residues 221-240 was immunogenic in mice. Ab raised against OspA peptide surface labeled B. burgdorferi in IFAs and displayed potent Ab mediated-complement dependent bactericidal activity. BLAST analyses identified several variants of OspA and a closely related sequence in OspB. It is our hypothesis that integration of the OspA epitope into a multivalent-OspC based chimeric epitope based vaccine antigen (chimeritope) could result in a subunit vaccine that protects against Lyme disease through synergistic mechanisms. |
Author | Marconi, Richard T Oliver, Lee D Earnhart, Christopher G Izac, Jerilyn R |
Author_xml | – sequence: 1 fullname: Izac, Jerilyn R – sequence: 2 fullname: Oliver, Lee D – sequence: 3 fullname: Earnhart, Christopher G – sequence: 4 fullname: Marconi, Richard T |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/28479174$$D View this record in MEDLINE/PubMed |
BookMark | eNqFUstuEzEUHaEimhY-AWSJDZuE67HnYRatqopHpEhdABI7y2PfIQ4z9mA7kfJZ_CEOCQW6YWNbvsfnnnN9Looz5x0WxXMKCwq0fr1Z7JTW1uGiBNosgC-gEY-KGW0bNi8r2p4VMyhrPucUvpwXFzFuAKBiVDwpzsuWN4I2fFb8WBp0yfZWq2S9I74nihjsM7EhQ15VIDjZ5Cck1pG0RnIXpxsyBZ_Q_sIf7lb7EYmxEVVEEicbvF5jwpiLKhEcrLYpkk7phCGfjRqIym07b_YkYJy8ixjfkOU4DSclkfQ-kJPHrGiHg5_GrPVp8bhXQ8Rnp_2y-Pzu7afbD_PV3fvl7c1qrqsK0twwBliZVmjUotOVUILWjOkG66bHXquOQl-KqmMVN2hK4NowDoIa03HoOLssro6807Yb0ejcOqhBTsGOKuylV1b-W3F2Lb_6nWxLYJzSTPDqRBD89y3GJEcbNQ6Dcui3UdJW1Jzysmkz9OUD6MZvg8v2JBVAWVtT0WRUdUTp4GMM2N-LoSAPoZAbeRqYPIRCApc5FPndi7-d3L_6nYIMuD4CMM9zZzHIqC06jcYG1Ekab__b4uoBg87hyV85fMM9xj9uZCwlyI-HZB6CSRsGVQsN-wnUzOeR |
CitedBy_id | crossref_primary_10_1007_s10482_018_1048_2 crossref_primary_10_1016_j_vetimm_2022_110471 crossref_primary_10_1128_mBio_01006_18 crossref_primary_10_1016_j_jtbi_2020_110245 crossref_primary_10_1016_j_jvacx_2023_100382 crossref_primary_10_1016_j_vaccine_2019_02_007 crossref_primary_10_1016_j_tvjl_2020_105504 crossref_primary_10_1021_acs_bioconjchem_9b00167 crossref_primary_10_1142_S021833902250022X crossref_primary_10_1016_j_vaccine_2019_10_073 crossref_primary_10_1371_journal_ppat_1006959 crossref_primary_10_1016_j_jvacx_2021_100089 crossref_primary_10_7759_cureus_43112 crossref_primary_10_1016_j_cca_2020_04_002 crossref_primary_10_1016_j_vaccine_2020_01_027 crossref_primary_10_1128_IAI_00182_18 crossref_primary_10_1016_j_cvsm_2019_02_007 crossref_primary_10_3389_fmicb_2018_01682 crossref_primary_10_1371_journal_pone_0291382 crossref_primary_10_3389_fmed_2021_666554 crossref_primary_10_1016_S1473_3099_23_00210_4 crossref_primary_10_1128_IAI_00246_19 |
Cites_doi | 10.1016/S0264-410X(00)00520-X 10.1128/CVI.00409-06 10.1126/science.281.5377.703 10.1007/BF02962365 10.1046/j.1365-2958.2003.03537.x 10.1089/vbz.2010.0254 10.4161/hv.4661 10.1016/S0891-5520(05)70047-7 10.4049/jimmunol.151.2.900 10.1590/S1984-29612014040 10.1016/S1286-4579(01)01435-6 10.1128/IAI.61.7.2774-2779.1993 10.1177/000992280204100107 10.1128/JB.00085-08 10.1042/bst0310108 10.1089/153036603768395825 10.1007/s004300050083 10.1016/j.tvjl.2016.11.001 10.1128/JCM.41.11.5059-5065.2003 10.1111/jvim.13973 10.1016/j.prevetmed.2012.07.002 10.1093/cid/ciq117 10.1038/37551 10.1073/pnas.0305680101 10.1128/IAI.65.11.4661-4667.1997 10.3347/kjp.2016.54.1.97 10.1586/14760584.2013.824704 10.1073/pnas.90.9.4092 10.1128/IAI.00410-08 10.1016/j.jmb.2005.04.066 10.1089/153036601750137705 10.1128/IAI.01542-15 10.1017/S0950268806007096 10.1128/JCM.37.12.3965-3970.1999 10.1128/IAI.68.1.411-414.2000 10.1128/IAI.01950-05 10.1111/j.1365-2958.1989.tb00194.x 10.1128/CVI.00406-14 10.1128/CVI.00099-06 10.1128/JCM.37.7.2137-2141.1999 10.1016/j.vaccine.2006.07.052 10.1128/IAI.62.5.2037-2045.1994 10.1073/pnas.89.12.5418 10.1084/jem.183.1.271 10.1128/JCM.30.11.2830-2834.1992 10.1128/jb.176.15.4572-4582.1994 10.1110/ps.9.5.1002 10.1080/01652176.2002.9695196 10.1292/jvms.12-0449 10.1128/IAI.63.6.2221-2227.1995 10.1128/IAI.67.1.173-181.1999 10.1016/j.vaccine.2006.12.051 10.1016/j.tvjl.2013.07.019 10.1016/j.pt.2010.01.006 10.1128/CVI.05004-11 |
ContentType | Journal Article |
Copyright | 2017 Copyright © 2017. Published by Elsevier Ltd. Copyright Elsevier Limited May 31, 2017 |
Copyright_xml | – notice: 2017 – notice: Copyright © 2017. Published by Elsevier Ltd. – notice: Copyright Elsevier Limited May 31, 2017 |
DBID | 6I. AAFTH CGR CUY CVF ECM EIF NPM AAYXX CITATION 3V. 7QL 7RV 7T2 7T5 7U9 7X7 7XB 88C 88E 8AO 8C1 8FE 8FH 8FI 8FJ 8FK 8G5 ABUWG AFKRA AZQEC BBNVY BENPR BHPHI C1K CCPQU DWQXO FYUFA GHDGH GNUQQ GUQSH H94 HCIFZ K9- K9. KB0 LK8 M0R M0S M0T M1P M2O M7N M7P MBDVC NAPCQ PQEST PQQKQ PQUKI Q9U 7X8 5PM |
DOI | 10.1016/j.vaccine.2017.04.079 |
DatabaseName | ScienceDirect Open Access Titles Elsevier:ScienceDirect:Open Access Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef ProQuest Central (Corporate) Bacteriology Abstracts (Microbiology B) Nursing & Allied Health Source (ProQuest) Health and Safety Science Abstracts (Full archive) Immunology Abstracts Virology and AIDS Abstracts ProQuest Health & Medical Collection ProQuest Central (purchase pre-March 2016) Healthcare Administration Database (Alumni) Medical Database (Alumni Edition) ProQuest Pharma Collection ProQuest Public Health Database ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) Research Library (Alumni Edition) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Collection AUTh Library subscriptions: ProQuest Central ProQuest Natural Science Collection Environmental Sciences and Pollution Management ProQuest One Community College ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student Research Library Prep AIDS and Cancer Research Abstracts SciTech Premium Collection Consumer Health Database ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) Biological Sciences ProQuest Consumer Health Database Health & Medical Collection (Alumni Edition) ProQuest Healthcare Administration Database PML(ProQuest Medical Library) ProQuest Research Library Algology Mycology and Protozoology Abstracts (Microbiology C) Biological Science Database Research Library (Corporate) Nursing & Allied Health Premium ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central Basic MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef Research Library Prep ProQuest Central Student ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College Research Library (Alumni Edition) ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Family Health (Alumni Edition) Environmental Sciences and Pollution Management ProQuest Central Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Bacteriology Abstracts (Microbiology B) Algology Mycology and Protozoology Abstracts (Microbiology C) Biological Science Collection AIDS and Cancer Research Abstracts ProQuest Research Library Health & Safety Science Abstracts ProQuest Medical Library (Alumni) ProQuest Public Health Virology and AIDS Abstracts ProQuest Biological Science Collection ProQuest Central Basic ProQuest Family Health ProQuest One Academic Eastern Edition ProQuest Health Management ProQuest Nursing & Allied Health Source ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest Health Management (Alumni Edition) Immunology Abstracts ProQuest Nursing & Allied Health Source (Alumni) ProQuest One Academic ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | Research Library Prep MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BENPR name: AUTh Library subscriptions: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Veterinary Medicine Biology Pharmacy, Therapeutics, & Pharmacology |
EISSN | 1873-2518 |
EndPage | 3185 |
ExternalDocumentID | 10_1016_j_vaccine_2017_04_079 28479174 S0264410X17305807 1_s2_0_S0264410X17305807 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GeographicLocations | Asia United States--US Europe |
GeographicLocations_xml | – name: Europe – name: United States--US – name: Asia |
GroupedDBID | - 0R 1 1- 123 1B1 1P 1RT 1~. 1~5 29Q 3V. 4.4 457 4G. 53G 5RE 5VS 7-5 71M 7RV 7X7 88E 8AO 8C1 8FE 8FH 8FI 8FJ 8G5 8P 9JM AAAJQ AABNK AACTN AAEDT AAIAV AAIKJ AAKOC AALMO AALRI AAOAW AAQFI AAQXK AARKO AAXUO ABBQC ABFLS ABFNM ABFRF ABKYH ABLVK ABMAC ABMZM ABPIF ABPTK ABQIS ABRWV ABUWG ABXDB ABYKQ ACDAQ ACGFO ACGFS ACIUM ACPRK ACRLP ADALY ADBBV ADEZE ADFRT AEBSH AEFWE AEKER AENEX AESVU AEVXI AEXOQ AFCTW AFKRA AFKWA AFRAH AFRHN AFTJW AFXIZ AGEKW AGGSO AGHFR AGUBO AGYEJ AHHHB AHMBA AIEXJ AIKHN AITUG AJBFU AJOXV AJRQY AJUYK ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ ANZVX AQUVI ASPBG AVWKF AZFZN AZQEC BBAFP BBNVY BENPR BHPHI BKEYQ BKNYI BKOJK BLXMC BNPGV BPHCQ BVXVI CJTIS CNWQP CS3 DWQXO EBS EFJIC EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU FO FYUFA G- G-2 G-Q GBLVA GJ GNUQQ GUQSH HCIFZ HEJ HLV HMG HMK HMO HVGLF HX HZ IHE IPNFZ J1W K K9- KOM L7B LCYCR LK8 LUGTX LW9 M M0R M0T M1P M29 M2O M41 M7P MO0 N9A NAPCQ O-L O9 O9- OAUVE OK0 OZT P-8 P-9 P2P PC. PQEST PQQKQ PQUKI PROAC PSQYO Q38 QYZTP R2- RIG ROL RPZ SAB SAE SCC SDF SDG SDP SES SEW SIN SNL SPCBC SSH SSI SSZ SVS T5K UV1 WH7 WOW WUQ XPP Z5R ZGI ZXP --- --K --M .1- .FO .~1 0R~ 1P~ 6I. 8P~ AAEDW AAFTH ABJNI AXJTR CCPQU EFLBG FYGXN HMCUK O9~ UKHRP ~G- AAHBH AAXKI AKRWK ALIPV CGR CUY CVF ECM EIF NPM .GJ 0SF AAYXX ADMUD ADVLN AFJKZ CITATION HX~ HZ~ 7QL 7T2 7T5 7U9 7XB 8FK C1K H94 K9. M7N MBDVC Q9U 7X8 5PM |
ID | FETCH-LOGICAL-c550t-d330e5d89cec9bc59a91633c7e67fefcab10f295b354ded204cd34091ddb40b43 |
IEDL.DBID | AIKHN |
ISSN | 0264-410X |
IngestDate | Tue Sep 17 21:25:50 EDT 2024 Sat Aug 17 00:55:19 EDT 2024 Thu Oct 10 21:09:47 EDT 2024 Thu Sep 26 16:15:57 EDT 2024 Sat Sep 28 08:49:20 EDT 2024 Fri Feb 23 02:21:16 EST 2024 Thu Aug 18 17:13:40 EDT 2022 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 24 |
Keywords | Outer surface protein A Lyme disease OspC Ixodes ticks Lyme vaccine Chimeritope VANGUARDcrLyme |
Language | English |
License | This is an open access article under the CC BY license. Copyright © 2017. Published by Elsevier Ltd. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c550t-d330e5d89cec9bc59a91633c7e67fefcab10f295b354ded204cd34091ddb40b43 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 JRI, LDO, and CGE were all directly involved in performing the experiments detailed in this study. RTM served as the principal investigator and contributed to experimental design and data interpretation. Contributors |
OpenAccessLink | https://www.sciencedirect.com/science/article/pii/S0264410X17305807 |
PMID | 28479174 |
PQID | 1901386197 |
PQPubID | 105530 |
PageCount | 8 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_8203411 proquest_miscellaneous_1896414278 proquest_journals_1901386197 crossref_primary_10_1016_j_vaccine_2017_04_079 pubmed_primary_28479174 elsevier_sciencedirect_doi_10_1016_j_vaccine_2017_04_079 elsevier_clinicalkeyesjournals_1_s2_0_S0264410X17305807 |
PublicationCentury | 2000 |
PublicationDate | 2017-05-31 |
PublicationDateYYYYMMDD | 2017-05-31 |
PublicationDate_xml | – month: 05 year: 2017 text: 2017-05-31 day: 31 |
PublicationDecade | 2010 |
PublicationPlace | Netherlands |
PublicationPlace_xml | – name: Netherlands – name: Kidlington |
PublicationTitle | Vaccine |
PublicationTitleAlternate | Vaccine |
PublicationYear | 2017 |
Publisher | Elsevier Ltd Elsevier Limited |
Publisher_xml | – name: Elsevier Ltd – name: Elsevier Limited |
References | Lee, Yun, Choi (b0025) 2016; 54 Tsao, Barbour, Luke, Fikrig, Fish (b0090) 2001; 1 Wagner, Erb (b0015) 2012; 107 Rhodes, Earnhart, Mather, Meeus, Marconi (b0245) 2013; 198 de Silva, Telford, Brunet, Barthold, Fikrig (b0085) 1996; 183 Zundorf, Dingermann (b0155) 2008; 37 Bockenstedt, Hodzic, Feng (b0220) 1997; 65 Miller, Oliver, Tegels (b0225) 2016; 84 Ma, Gingrich-Baker, Franchi, Bulger, Coughlin (b0250) 1995; 63 Srivastava, de Silva (b0080) 2008; 190 Sadziene, Jonsson, Bergstrom, Bright, Kennedy, Barbour (b0255) 1994; 62 Fikrig, Tao, Kantor, Barthold, Flavell (b0110) 1993; 90 Wormser (b0145) 1999; 13 Akin, McHugh, Flavell, Fikrig, Steere (b0105) 1999; 67 Battisti, Bono, Rosa, Schrumpf, Schwan, Policastro (b0235) 2008; 76 Montandon, Yoshinari, Milagres (b0030) 2015; 23 Kiss, Cadar, Krupaci (b0040) 2011; 11 Nigrovic, Thompson (b0050) 2007; 135 Funk, Pleasant, Witonsky, Reeder, Werre, Hodgson (b0020) 2016; 30 Bergström, Bundoc, Barbour (b0055) 1989; 3 Little, Heise, Blagburn, Callister, Mead (b0005) 2010; 26 Earnhart, Marconi (b0120) 2009 Wormser, Nowakowski, Nadelman (b0150) 1998; 26 Earnhart, Marconi (b0190) 2007; 14 Marconi, Samuels, Landry, Garon (b0290) 1994; 176 Gilmore, Piesman (b0215) 2000; 68 Koide, Yang, Huang, Dunn, Luft (b0265) 2005; 350 Piesman, Zeidner, Schneider (b0075) 2003; 3 Lagal, Postic, Ruzic-Sabljic, Baranton (b0295) 2003; 41 Earnhart, Marconi (b0135) 2007; 3 Butler, Houwers, Jongejan, van der Kolk (b0010) 2005; 27 Obonyo, Munderloh, Fingerle, Wilske, Kurtti (b0060) 1999; 37 Willett, Meyer, Brown, Huber (b0175) 2004; 101 Marconi, Hohenberger, Jauris-Heipke (b0280) 1999; 37 Barone, Bohrer, Erhardt (b0045) 2002; 41 Schwan (b0200) 2003; 31 Fraser, Casjens, Huang (b0275) 1997; 390 Barrett, Portsmouth (b0185) 2013; 12 Alverson, Bundle, Sohaskey, Lybecker, Samuels (b0070) 2003; 48 Parenti (b0160) 1999; 63 Kalish, Leong, Steere (b0170) 1993; 61 Fikrig, Telford, Barthold, Kantor, Spielman, Flavell (b0095) 1992; 89 Wressnigg, Barrett, Pollabauer (b0180) 2014; 21 Gilmore, Mbow, Stevenson (b0065) 2001; 3 Marconi, Earnhart (b0115) 2010 Poland, Jacobson (b0140) 2001; 19 Bockenstedt, Fikrig, Barthold, Kantor, Flavell (b0270) 1993; 151 Fingerle, Liegl, Munderloh, Wilske (b0210) 1998; 187 Earnhart, Marconi (b0130) 2007; 25 Earnhart, Rhodes, Marconi (b0240) 2011; 18 Steere, Drouin, Glickstein (b0100) 2011; 52 Tilly, Krum, Bestor (b0205) 2006; 74 Oliver, Earnhart, Virgina-Rhodes, Theisen, Marconi (b0230) 2016; 218 Laus, Veronesi, Passamonti (b0035) 2013; 75 Legros, Jolivet-Reynaud, Battail-Poirot, Saint-Pierre, Forest (b0260) 2000; 9 Earnhart, Buckles, Marconi (b0125) 2007; 25 Gross, Forsthuber, Tary-Lehmann (b0165) 1998; 281 Buckles, Earnhart, Marconi (b0195) 2006; 13 Marconi, Garon (b0285) 1992; 30 Lee (10.1016/j.vaccine.2017.04.079_b0025) 2016; 54 Schwan (10.1016/j.vaccine.2017.04.079_b0200) 2003; 31 Ma (10.1016/j.vaccine.2017.04.079_b0250) 1995; 63 Koide (10.1016/j.vaccine.2017.04.079_b0265) 2005; 350 Earnhart (10.1016/j.vaccine.2017.04.079_b0130) 2007; 25 Miller (10.1016/j.vaccine.2017.04.079_b0225) 2016; 84 Kiss (10.1016/j.vaccine.2017.04.079_b0040) 2011; 11 Fikrig (10.1016/j.vaccine.2017.04.079_b0110) 1993; 90 Sadziene (10.1016/j.vaccine.2017.04.079_b0255) 1994; 62 Marconi (10.1016/j.vaccine.2017.04.079_b0285) 1992; 30 Steere (10.1016/j.vaccine.2017.04.079_b0100) 2011; 52 Marconi (10.1016/j.vaccine.2017.04.079_b0290) 1994; 176 Bockenstedt (10.1016/j.vaccine.2017.04.079_b0220) 1997; 65 Gross (10.1016/j.vaccine.2017.04.079_b0165) 1998; 281 Fraser (10.1016/j.vaccine.2017.04.079_b0275) 1997; 390 Willett (10.1016/j.vaccine.2017.04.079_b0175) 2004; 101 Rhodes (10.1016/j.vaccine.2017.04.079_b0245) 2013; 198 Funk (10.1016/j.vaccine.2017.04.079_b0020) 2016; 30 Poland (10.1016/j.vaccine.2017.04.079_b0140) 2001; 19 Gilmore (10.1016/j.vaccine.2017.04.079_b0215) 2000; 68 Piesman (10.1016/j.vaccine.2017.04.079_b0075) 2003; 3 de Silva (10.1016/j.vaccine.2017.04.079_b0085) 1996; 183 Zundorf (10.1016/j.vaccine.2017.04.079_b0155) 2008; 37 Little (10.1016/j.vaccine.2017.04.079_b0005) 2010; 26 Oliver (10.1016/j.vaccine.2017.04.079_b0230) 2016; 218 Earnhart (10.1016/j.vaccine.2017.04.079_b0120) 2009 Alverson (10.1016/j.vaccine.2017.04.079_b0070) 2003; 48 Butler (10.1016/j.vaccine.2017.04.079_b0010) 2005; 27 Bergström (10.1016/j.vaccine.2017.04.079_b0055) 1989; 3 Tilly (10.1016/j.vaccine.2017.04.079_b0205) 2006; 74 Earnhart (10.1016/j.vaccine.2017.04.079_b0240) 2011; 18 Legros (10.1016/j.vaccine.2017.04.079_b0260) 2000; 9 Barrett (10.1016/j.vaccine.2017.04.079_b0185) 2013; 12 Laus (10.1016/j.vaccine.2017.04.079_b0035) 2013; 75 Montandon (10.1016/j.vaccine.2017.04.079_b0030) 2015; 23 Barone (10.1016/j.vaccine.2017.04.079_b0045) 2002; 41 Battisti (10.1016/j.vaccine.2017.04.079_b0235) 2008; 76 Lagal (10.1016/j.vaccine.2017.04.079_b0295) 2003; 41 Earnhart (10.1016/j.vaccine.2017.04.079_b0135) 2007; 3 Marconi (10.1016/j.vaccine.2017.04.079_b0280) 1999; 37 Fingerle (10.1016/j.vaccine.2017.04.079_b0210) 1998; 187 Obonyo (10.1016/j.vaccine.2017.04.079_b0060) 1999; 37 Wagner (10.1016/j.vaccine.2017.04.079_b0015) 2012; 107 Nigrovic (10.1016/j.vaccine.2017.04.079_b0050) 2007; 135 Fikrig (10.1016/j.vaccine.2017.04.079_b0095) 1992; 89 Marconi (10.1016/j.vaccine.2017.04.079_b0115) 2010 Parenti (10.1016/j.vaccine.2017.04.079_b0160) 1999; 63 Buckles (10.1016/j.vaccine.2017.04.079_b0195) 2006; 13 Kalish (10.1016/j.vaccine.2017.04.079_b0170) 1993; 61 Akin (10.1016/j.vaccine.2017.04.079_b0105) 1999; 67 Earnhart (10.1016/j.vaccine.2017.04.079_b0190) 2007; 14 Wormser (10.1016/j.vaccine.2017.04.079_b0150) 1998; 26 Wressnigg (10.1016/j.vaccine.2017.04.079_b0180) 2014; 21 Gilmore (10.1016/j.vaccine.2017.04.079_b0065) 2001; 3 Wormser (10.1016/j.vaccine.2017.04.079_b0145) 1999; 13 Earnhart (10.1016/j.vaccine.2017.04.079_b0125) 2007; 25 Srivastava (10.1016/j.vaccine.2017.04.079_b0080) 2008; 190 Tsao (10.1016/j.vaccine.2017.04.079_b0090) 2001; 1 Bockenstedt (10.1016/j.vaccine.2017.04.079_b0270) 1993; 151 |
References_xml | – volume: 52 start-page: s259 year: 2011 end-page: s265 ident: b0100 article-title: Relationship between immunity to publication-title: Clin Infect Dis contributor: fullname: Glickstein – volume: 176 start-page: 4572 year: 1994 end-page: 4582 ident: b0290 article-title: Analysis of the distribution and molecular heterogeneity of the ospD gene among the Lyme disease spirochetes: evidence for lateral gene exchange publication-title: J Bacteriol contributor: fullname: Garon – volume: 26 start-page: 208 year: 1998 end-page: 212 ident: b0150 article-title: Efficacy of an OspA vaccine preparation for prevention of Lyme disease in New York State publication-title: Infection contributor: fullname: Nadelman – volume: 12 start-page: 973 year: 2013 end-page: 975 ident: b0185 article-title: A novel multivalent OspA vaccine against Lyme borreliosis shows promise in Phase I/II studies publication-title: Expert Rev Vaccines contributor: fullname: Portsmouth – volume: 13 start-page: 1162 year: 2006 end-page: 1165 ident: b0195 article-title: Analysis of antibody response in humans to the type A OspC loop 5 domain and assessment of the potential utility of the loop 5 epitope in Lyme disease vaccine development publication-title: Clin Vaccine Immunol contributor: fullname: Marconi – volume: 62 start-page: 2037 year: 1994 end-page: 2045 ident: b0255 article-title: A bactericidal antibody to publication-title: Infect Immun contributor: fullname: Barbour – volume: 41 start-page: 33 year: 2002 end-page: 36 ident: b0045 article-title: Parental knowledge of and attitudes toward LYMErix (recombinant Osp–a lyme vaccine) publication-title: Clin Pediatr (Phila) contributor: fullname: Erhardt – volume: 9 start-page: 1002 year: 2000 end-page: 1010 ident: b0260 article-title: Characterization of an anti- publication-title: Protein Sci contributor: fullname: Forest – volume: 135 start-page: 1 year: 2007 end-page: 8 ident: b0050 article-title: The Lyme vaccine: a cautionary tale publication-title: Epidemiol Infect contributor: fullname: Thompson – volume: 3 start-page: 125 year: 2003 end-page: 132 ident: b0075 article-title: Dynamic changes in publication-title: Vector Borne Zoonotic Dis contributor: fullname: Schneider – volume: 218 start-page: 27 year: 2016 end-page: 33 ident: b0230 article-title: Antibody profiling of canine IgG responses to the OspC protein of the Lyme disease spirochetes supports a multivalent approach in vaccine and diagnostic assay development publication-title: Vet J contributor: fullname: Marconi – volume: 14 start-page: 628 year: 2007 end-page: 634 ident: b0190 article-title: OspC phylogenetic analyses support the feasibility of a broadly protective polyvalent chimeric Lyme disease vaccine publication-title: Clin Vaccine Immunol contributor: fullname: Marconi – volume: 25 start-page: 3419 year: 2007 end-page: 3427 ident: b0130 article-title: Construction and analysis of variants of a polyvalent Lyme disease vaccine: approaches for improving the immune response to chimeric vaccinogens publication-title: Vaccine contributor: fullname: Marconi – volume: 48 start-page: 1665 year: 2003 end-page: 1677 ident: b0070 article-title: Transcriptional regulation of the publication-title: Mol Microbiol contributor: fullname: Samuels – volume: 61 start-page: 2774 year: 1993 end-page: 2779 ident: b0170 article-title: Association of treatment-resistant chronic Lyme arthritis with HLA-DR4 and antibody reactivity to OspA and OspB of publication-title: Infect Immun contributor: fullname: Steere – volume: 89 start-page: 5418 year: 1992 end-page: 5421 ident: b0095 article-title: Elimination of publication-title: Proc Natl Acad Sci USA contributor: fullname: Flavell – volume: 11 start-page: 1259 year: 2011 end-page: 1262 ident: b0040 article-title: Serological reactivity to publication-title: Vector Borne Zoonotic Dis contributor: fullname: Krupaci – volume: 37 start-page: 2137 year: 1999 end-page: 2141 ident: b0060 article-title: in tick cell culture modulates expression of outer surface proteins A and C in response to temperature publication-title: J Clin Microbiol contributor: fullname: Kurtti – volume: 190 start-page: 3429 year: 2008 end-page: 3433 ident: b0080 article-title: Reciprocal expression of ospA and ospC in single cells of publication-title: J Bacteriol contributor: fullname: de Silva – volume: 74 start-page: 3554 year: 2006 end-page: 3564 ident: b0205 article-title: OspC protein required exclusively in a crucial early stage of mammalian infection publication-title: Infect Immun contributor: fullname: Bestor – volume: 37 start-page: 38 year: 2008 end-page: 39 ident: b0155 article-title: Death of a vaccine–the fall of LYMErix publication-title: Pharm Unserer Zeit contributor: fullname: Dingermann – volume: 151 start-page: 900 year: 1993 end-page: 906 ident: b0270 article-title: Inability of truncated recombinant Osp A proteins to elicit protective immunity to publication-title: J Immunol contributor: fullname: Flavell – volume: 107 start-page: 275 year: 2012 end-page: 279 ident: b0015 article-title: Dogs and horses with antibodies to outer-surface protein C as on-time sentinels for ticks infected with publication-title: Prev Vet Med contributor: fullname: Erb – volume: 101 start-page: 1303 year: 2004 end-page: 1308 ident: b0175 article-title: An effective second-generation outer surface protein A-derived Lyme vaccine that eliminates a potentially autoreactive T cell epitope publication-title: Proc Natl Acad Sci USA contributor: fullname: Huber – volume: 26 start-page: 213 year: 2010 end-page: 218 ident: b0005 article-title: Lyme borreliosis in dogs and humans in the USA publication-title: Trends Parasitol contributor: fullname: Mead – volume: 76 start-page: 5228 year: 2008 end-page: 5237 ident: b0235 article-title: Outer surface protein A protects Lyme disease spirochetes from acquired host immunity in the tick vector publication-title: Infect Immun contributor: fullname: Policastro – volume: 75 start-page: 715 year: 2013 end-page: 720 ident: b0035 article-title: Prevalence of tick borne pathogens in horses from Italy publication-title: J Vet Med Sci contributor: fullname: Passamonti – volume: 84 start-page: 2051 year: 2016 end-page: 2058 ident: b0225 article-title: The Treponema denticola FhbB Protein Is a Dominant Early Antigen That Elicits FhbB Variant-Specific Antibodies That Block Factor H Binding and Cleavage by Dentilisin publication-title: Infect Immun contributor: fullname: Tegels – volume: 23 start-page: 287 year: 2015 end-page: 290 ident: b0030 article-title: Evidence of Borrelia in wild and domestic mammals from the state of Minas Gerais, Brazil publication-title: Rev Bras Parasitol Vet contributor: fullname: Milagres – volume: 27 start-page: 146 year: 2005 end-page: 156 ident: b0010 article-title: infections with special reference to horses. A review publication-title: Vet Q contributor: fullname: van der Kolk – volume: 25 start-page: 466 year: 2007 end-page: 480 ident: b0125 article-title: Development of an OspC-based tetravalent, recombinant, chimeric vaccinogen that elicits bactericidal antibody against diverse Lyme disease spirochete strains publication-title: Vaccine contributor: fullname: Marconi – volume: 41 start-page: 5059 year: 2003 end-page: 5065 ident: b0295 article-title: Genetic diversity among Borrelia strains determined by single-strand conformation polymorphism analysis of the ospC gene and its association with invasiveness publication-title: J Clin Microbiol contributor: fullname: Baranton – volume: 198 start-page: 412 year: 2013 end-page: 418 ident: b0245 article-title: Identification of publication-title: Vet J contributor: fullname: Marconi – volume: 21 start-page: 1490 year: 2014 end-page: 1499 ident: b0180 article-title: A Novel multivalent OspA vaccine against Lyme borreliosis is safe and immunogenic in an adult population previously infected with publication-title: Clin Vaccine Immunol contributor: fullname: Pollabauer – start-page: 467 year: 2010 end-page: 486 ident: b0115 article-title: Lyme disease vaccines publication-title: Borrelia: molecular biology, host interaction and pathogenesis contributor: fullname: Earnhart – volume: 183 start-page: 271 year: 1996 end-page: 275 ident: b0085 article-title: OspA is an arthropod-specific transmission-blocking Lyme disease vaccine publication-title: J Exp Med contributor: fullname: Fikrig – volume: 54 start-page: 97 year: 2016 end-page: 101 ident: b0025 article-title: Serological Detection of publication-title: Korean J Parasitol contributor: fullname: Choi – volume: 31 start-page: 108 year: 2003 end-page: 112 ident: b0200 article-title: Temporal regulation of outer surface proteins of the Lyme-disease spirochaete publication-title: Biochem Soc Trans contributor: fullname: Schwan – volume: 13 start-page: 135 year: 1999 end-page: 148 ident: b0145 article-title: Vaccination as a modality to prevent Lyme disease. A status report publication-title: Infect Dis Clin North Am contributor: fullname: Wormser – volume: 19 start-page: 2303 year: 2001 end-page: 2308 ident: b0140 article-title: The prevention of Lyme disease with vaccine publication-title: Vaccine contributor: fullname: Jacobson – start-page: 1032 year: 2009 end-page: 1060 ident: b0120 article-title: Lyme disease publication-title: Vaccines for biodefense and emerging and neglected diseases contributor: fullname: Marconi – volume: 187 start-page: 121 year: 1998 end-page: 126 ident: b0210 article-title: Expression of outer surface proteins A and C of publication-title: Med Microbiol Immunol contributor: fullname: Wilske – volume: 37 start-page: 3965 year: 1999 end-page: 3970 ident: b0280 article-title: Genetic analysis of Borrelia garinii OspA serotype 4 strains associated with neuroborreliosis: evidence for extensive genetic homogeneity publication-title: J Clin Microbiol contributor: fullname: Jauris-Heipke – volume: 390 start-page: 580 year: 1997 end-page: 586 ident: b0275 article-title: Genomic sequence of a Lyme disease spirochaete, publication-title: Nature contributor: fullname: Huang – volume: 63 start-page: 2221 year: 1995 end-page: 2227 ident: b0250 article-title: Molecular analysis of neutralizing epitopes on outer surface proteins A and B of publication-title: Infect Immun contributor: fullname: Coughlin – volume: 68 start-page: 411 year: 2000 end-page: 414 ident: b0215 article-title: Inhibition of publication-title: Infect Immun contributor: fullname: Piesman – volume: 281 start-page: 703 year: 1998 end-page: 706 ident: b0165 article-title: Identification of LFA-1 as a candidate autoantigen in treatment-resistant Lyme arthritis publication-title: Science contributor: fullname: Tary-Lehmann – volume: 18 start-page: 901 year: 2011 end-page: 906 ident: b0240 article-title: Disulfide-mediated oligomer formation in publication-title: Clin Vaccine Immunol contributor: fullname: Marconi – volume: 3 start-page: 479 year: 1989 end-page: 486 ident: b0055 article-title: Molecular analysis of the linear plasmid encoded major surface proteins, OspA and OspB, of the Lyme disease spirochete publication-title: Mol Microbiol contributor: fullname: Barbour – volume: 350 start-page: 290 year: 2005 end-page: 299 ident: b0265 article-title: Structure-based design of a second-generation Lyme disease vaccine based on a C-terminal fragment of publication-title: J Mol Biol contributor: fullname: Luft – volume: 90 start-page: 4092 year: 1993 end-page: 4096 ident: b0110 article-title: Evasion of protective immunity bu publication-title: Proc Natl Acad Sci USA contributor: fullname: Flavell – volume: 30 start-page: 2830 year: 1992 end-page: 2834 ident: b0285 article-title: Development of polymerase chain reaction primer sets for diagnosis of Lyme disease and for species-specific identification of Lyme disease isolates by 16S rRNA signature nucleotide analysis publication-title: J Clin Microbiol contributor: fullname: Garon – volume: 63 start-page: 570 year: 1999 ident: b0160 article-title: Lyme disease vaccine–LYMErix publication-title: Conn Med contributor: fullname: Parenti – volume: 3 start-page: 281 year: 2007 end-page: 289 ident: b0135 article-title: An octavalent lyme disease vaccine induces antibodies that recognize all incorporated OspC type-specific sequences publication-title: Hum Vaccin contributor: fullname: Marconi – volume: 3 start-page: 799 year: 2001 end-page: 808 ident: b0065 article-title: Analysis of publication-title: Microbes Infect contributor: fullname: Stevenson – volume: 65 start-page: 4661 year: 1997 end-page: 4667 ident: b0220 article-title: strain-specific OspC mediated immunity in mice publication-title: Infect Immun contributor: fullname: Feng – volume: 67 start-page: 173 year: 1999 end-page: 181 ident: b0105 article-title: The immunoglobulin (IgG) antibody response to OspA and OspB correlates with severe and prolonged Lyme arthritis and the IgG response to P35 correlates with mild and brief arthritis publication-title: Infect Immun contributor: fullname: Steere – volume: 1 start-page: 65 year: 2001 end-page: 74 ident: b0090 article-title: OspA immunization decreases transmission of publication-title: Vector Borne Zoonotic Dis contributor: fullname: Fish – volume: 30 start-page: 1300 year: 2016 end-page: 1304 ident: b0020 article-title: Seroprevalence of publication-title: J Vet Intern Med contributor: fullname: Hodgson – volume: 19 start-page: 2303 issue: 17–19 year: 2001 ident: 10.1016/j.vaccine.2017.04.079_b0140 article-title: The prevention of Lyme disease with vaccine publication-title: Vaccine doi: 10.1016/S0264-410X(00)00520-X contributor: fullname: Poland – volume: 14 start-page: 628 issue: 5 year: 2007 ident: 10.1016/j.vaccine.2017.04.079_b0190 article-title: OspC phylogenetic analyses support the feasibility of a broadly protective polyvalent chimeric Lyme disease vaccine publication-title: Clin Vaccine Immunol doi: 10.1128/CVI.00409-06 contributor: fullname: Earnhart – volume: 281 start-page: 703 year: 1998 ident: 10.1016/j.vaccine.2017.04.079_b0165 article-title: Identification of LFA-1 as a candidate autoantigen in treatment-resistant Lyme arthritis publication-title: Science doi: 10.1126/science.281.5377.703 contributor: fullname: Gross – volume: 26 start-page: 208 issue: 4 year: 1998 ident: 10.1016/j.vaccine.2017.04.079_b0150 article-title: Efficacy of an OspA vaccine preparation for prevention of Lyme disease in New York State publication-title: Infection doi: 10.1007/BF02962365 contributor: fullname: Wormser – volume: 48 start-page: 1665 year: 2003 ident: 10.1016/j.vaccine.2017.04.079_b0070 article-title: Transcriptional regulation of the ospAB and ospC promoters from Borrelia burgdorferi publication-title: Mol Microbiol doi: 10.1046/j.1365-2958.2003.03537.x contributor: fullname: Alverson – volume: 11 start-page: 1259 issue: 9 year: 2011 ident: 10.1016/j.vaccine.2017.04.079_b0040 article-title: Serological reactivity to Borrelia burgdorferi sensu lato in dogs and horses from distinct areas in Romania publication-title: Vector Borne Zoonotic Dis doi: 10.1089/vbz.2010.0254 contributor: fullname: Kiss – volume: 3 start-page: 281 issue: 6 year: 2007 ident: 10.1016/j.vaccine.2017.04.079_b0135 article-title: An octavalent lyme disease vaccine induces antibodies that recognize all incorporated OspC type-specific sequences publication-title: Hum Vaccin doi: 10.4161/hv.4661 contributor: fullname: Earnhart – volume: 13 start-page: 135 issue: 1 year: 1999 ident: 10.1016/j.vaccine.2017.04.079_b0145 article-title: Vaccination as a modality to prevent Lyme disease. A status report publication-title: Infect Dis Clin North Am doi: 10.1016/S0891-5520(05)70047-7 contributor: fullname: Wormser – volume: 151 start-page: 900 issue: 2 year: 1993 ident: 10.1016/j.vaccine.2017.04.079_b0270 article-title: Inability of truncated recombinant Osp A proteins to elicit protective immunity to Borrelia burgdorferi in mice publication-title: J Immunol doi: 10.4049/jimmunol.151.2.900 contributor: fullname: Bockenstedt – volume: 23 start-page: 287 issue: 2 year: 2015 ident: 10.1016/j.vaccine.2017.04.079_b0030 article-title: Evidence of Borrelia in wild and domestic mammals from the state of Minas Gerais, Brazil publication-title: Rev Bras Parasitol Vet doi: 10.1590/S1984-29612014040 contributor: fullname: Montandon – volume: 3 start-page: 799 issue: 10 year: 2001 ident: 10.1016/j.vaccine.2017.04.079_b0065 article-title: Analysis of Borrelia burgdorferi gene expression during life cycle phases of the tick vector Ixodes scapularis publication-title: Microbes Infect doi: 10.1016/S1286-4579(01)01435-6 contributor: fullname: Gilmore – volume: 61 start-page: 2774 issue: 7 year: 1993 ident: 10.1016/j.vaccine.2017.04.079_b0170 article-title: Association of treatment-resistant chronic Lyme arthritis with HLA-DR4 and antibody reactivity to OspA and OspB of Borrelia burgdorferi publication-title: Infect Immun doi: 10.1128/IAI.61.7.2774-2779.1993 contributor: fullname: Kalish – volume: 41 start-page: 33 issue: 1 year: 2002 ident: 10.1016/j.vaccine.2017.04.079_b0045 article-title: Parental knowledge of and attitudes toward LYMErix (recombinant Osp–a lyme vaccine) publication-title: Clin Pediatr (Phila) doi: 10.1177/000992280204100107 contributor: fullname: Barone – volume: 190 start-page: 3429 issue: 10 year: 2008 ident: 10.1016/j.vaccine.2017.04.079_b0080 article-title: Reciprocal expression of ospA and ospC in single cells of Borrelia burgdorferi publication-title: J Bacteriol doi: 10.1128/JB.00085-08 contributor: fullname: Srivastava – volume: 31 start-page: 108 issue: Pt 1 year: 2003 ident: 10.1016/j.vaccine.2017.04.079_b0200 article-title: Temporal regulation of outer surface proteins of the Lyme-disease spirochaete Borrelia burgdorferi publication-title: Biochem Soc Trans doi: 10.1042/bst0310108 contributor: fullname: Schwan – volume: 3 start-page: 125 issue: 3 year: 2003 ident: 10.1016/j.vaccine.2017.04.079_b0075 article-title: Dynamic changes in Borrelia burgdorferi populations in Ixodes scapularis (Acari: Ixodidae) during transmission: studies at the mRNA level publication-title: Vector Borne Zoonotic Dis doi: 10.1089/153036603768395825 contributor: fullname: Piesman – volume: 187 start-page: 121 issue: 2 year: 1998 ident: 10.1016/j.vaccine.2017.04.079_b0210 article-title: Expression of outer surface proteins A and C of Borrelia burgdorferi in Ixodes ricinus ticks removed from humans publication-title: Med Microbiol Immunol doi: 10.1007/s004300050083 contributor: fullname: Fingerle – volume: 218 start-page: 27 year: 2016 ident: 10.1016/j.vaccine.2017.04.079_b0230 article-title: Antibody profiling of canine IgG responses to the OspC protein of the Lyme disease spirochetes supports a multivalent approach in vaccine and diagnostic assay development publication-title: Vet J doi: 10.1016/j.tvjl.2016.11.001 contributor: fullname: Oliver – volume: 41 start-page: 5059 issue: 11 year: 2003 ident: 10.1016/j.vaccine.2017.04.079_b0295 article-title: Genetic diversity among Borrelia strains determined by single-strand conformation polymorphism analysis of the ospC gene and its association with invasiveness publication-title: J Clin Microbiol doi: 10.1128/JCM.41.11.5059-5065.2003 contributor: fullname: Lagal – volume: 30 start-page: 1300 issue: 4 year: 2016 ident: 10.1016/j.vaccine.2017.04.079_b0020 article-title: Seroprevalence of Borrelia burgdorferi in Horses Presented for Coggins Testing in Southwest Virginia and Change in Positive Test Results Approximately 1 Year Later publication-title: J Vet Intern Med doi: 10.1111/jvim.13973 contributor: fullname: Funk – volume: 107 start-page: 275 issue: 3–4 year: 2012 ident: 10.1016/j.vaccine.2017.04.079_b0015 article-title: Dogs and horses with antibodies to outer-surface protein C as on-time sentinels for ticks infected with Borrelia burgdorferi in New York State in 2011 publication-title: Prev Vet Med doi: 10.1016/j.prevetmed.2012.07.002 contributor: fullname: Wagner – volume: 52 start-page: s259 issue: Suppl 3 year: 2011 ident: 10.1016/j.vaccine.2017.04.079_b0100 article-title: Relationship between immunity to Borrelia burgdorferi outer-surface protein A (OspA) and Lyme arthritis publication-title: Clin Infect Dis doi: 10.1093/cid/ciq117 contributor: fullname: Steere – volume: 390 start-page: 580 issue: 6660 year: 1997 ident: 10.1016/j.vaccine.2017.04.079_b0275 article-title: Genomic sequence of a Lyme disease spirochaete, Borrelia burgdorferi publication-title: Nature doi: 10.1038/37551 contributor: fullname: Fraser – start-page: 1032 year: 2009 ident: 10.1016/j.vaccine.2017.04.079_b0120 article-title: Lyme disease contributor: fullname: Earnhart – volume: 101 start-page: 1303 issue: 5 year: 2004 ident: 10.1016/j.vaccine.2017.04.079_b0175 article-title: An effective second-generation outer surface protein A-derived Lyme vaccine that eliminates a potentially autoreactive T cell epitope publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.0305680101 contributor: fullname: Willett – volume: 65 start-page: 4661 year: 1997 ident: 10.1016/j.vaccine.2017.04.079_b0220 article-title: Borrelia burgdorferi strain-specific OspC mediated immunity in mice publication-title: Infect Immun doi: 10.1128/IAI.65.11.4661-4667.1997 contributor: fullname: Bockenstedt – volume: 54 start-page: 97 issue: 1 year: 2016 ident: 10.1016/j.vaccine.2017.04.079_b0025 article-title: Serological Detection of Borrelia burgdorferi among Horses in Korea publication-title: Korean J Parasitol doi: 10.3347/kjp.2016.54.1.97 contributor: fullname: Lee – volume: 12 start-page: 973 issue: 9 year: 2013 ident: 10.1016/j.vaccine.2017.04.079_b0185 article-title: A novel multivalent OspA vaccine against Lyme borreliosis shows promise in Phase I/II studies publication-title: Expert Rev Vaccines doi: 10.1586/14760584.2013.824704 contributor: fullname: Barrett – volume: 90 start-page: 4092 year: 1993 ident: 10.1016/j.vaccine.2017.04.079_b0110 article-title: Evasion of protective immunity bu Borrelia burgdorferi by truncation of outer surface protein B publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.90.9.4092 contributor: fullname: Fikrig – volume: 76 start-page: 5228 issue: 11 year: 2008 ident: 10.1016/j.vaccine.2017.04.079_b0235 article-title: Outer surface protein A protects Lyme disease spirochetes from acquired host immunity in the tick vector publication-title: Infect Immun doi: 10.1128/IAI.00410-08 contributor: fullname: Battisti – volume: 350 start-page: 290 issue: 2 year: 2005 ident: 10.1016/j.vaccine.2017.04.079_b0265 article-title: Structure-based design of a second-generation Lyme disease vaccine based on a C-terminal fragment of Borrelia burgdorferi OspA publication-title: J Mol Biol doi: 10.1016/j.jmb.2005.04.066 contributor: fullname: Koide – volume: 1 start-page: 65 issue: 1 year: 2001 ident: 10.1016/j.vaccine.2017.04.079_b0090 article-title: OspA immunization decreases transmission of Borrelia burgdorferi spirochetes from infected Peromyscus leucopus mice to larval Ixodes scapularis ticks publication-title: Vector Borne Zoonotic Dis doi: 10.1089/153036601750137705 contributor: fullname: Tsao – volume: 63 start-page: 570 issue: 9 year: 1999 ident: 10.1016/j.vaccine.2017.04.079_b0160 article-title: Lyme disease vaccine–LYMErix publication-title: Conn Med contributor: fullname: Parenti – volume: 84 start-page: 2051 issue: 7 year: 2016 ident: 10.1016/j.vaccine.2017.04.079_b0225 article-title: The Treponema denticola FhbB Protein Is a Dominant Early Antigen That Elicits FhbB Variant-Specific Antibodies That Block Factor H Binding and Cleavage by Dentilisin publication-title: Infect Immun doi: 10.1128/IAI.01542-15 contributor: fullname: Miller – volume: 135 start-page: 1 issue: 1 year: 2007 ident: 10.1016/j.vaccine.2017.04.079_b0050 article-title: The Lyme vaccine: a cautionary tale publication-title: Epidemiol Infect doi: 10.1017/S0950268806007096 contributor: fullname: Nigrovic – volume: 37 start-page: 3965 issue: 12 year: 1999 ident: 10.1016/j.vaccine.2017.04.079_b0280 article-title: Genetic analysis of Borrelia garinii OspA serotype 4 strains associated with neuroborreliosis: evidence for extensive genetic homogeneity publication-title: J Clin Microbiol doi: 10.1128/JCM.37.12.3965-3970.1999 contributor: fullname: Marconi – volume: 37 start-page: 38 issue: 1 year: 2008 ident: 10.1016/j.vaccine.2017.04.079_b0155 article-title: Death of a vaccine–the fall of LYMErix publication-title: Pharm Unserer Zeit contributor: fullname: Zundorf – volume: 68 start-page: 411 issue: 1 year: 2000 ident: 10.1016/j.vaccine.2017.04.079_b0215 article-title: Inhibition of Borrelia burgdorferi migration from the midgut to the salivary glands following feeding by ticks on OspC-immunized mice publication-title: Infect Immun doi: 10.1128/IAI.68.1.411-414.2000 contributor: fullname: Gilmore – volume: 74 start-page: 3554 issue: 6 year: 2006 ident: 10.1016/j.vaccine.2017.04.079_b0205 article-title: Borrelia burgdorferi OspC protein required exclusively in a crucial early stage of mammalian infection publication-title: Infect Immun doi: 10.1128/IAI.01950-05 contributor: fullname: Tilly – volume: 3 start-page: 479 year: 1989 ident: 10.1016/j.vaccine.2017.04.079_b0055 article-title: Molecular analysis of the linear plasmid encoded major surface proteins, OspA and OspB, of the Lyme disease spirochete Borrelia burgdorferi publication-title: Mol Microbiol doi: 10.1111/j.1365-2958.1989.tb00194.x contributor: fullname: Bergström – volume: 21 start-page: 1490 issue: 11 year: 2014 ident: 10.1016/j.vaccine.2017.04.079_b0180 article-title: A Novel multivalent OspA vaccine against Lyme borreliosis is safe and immunogenic in an adult population previously infected with Borrelia burgdorferi sensu lato publication-title: Clin Vaccine Immunol doi: 10.1128/CVI.00406-14 contributor: fullname: Wressnigg – volume: 13 start-page: 1162 issue: 10 year: 2006 ident: 10.1016/j.vaccine.2017.04.079_b0195 article-title: Analysis of antibody response in humans to the type A OspC loop 5 domain and assessment of the potential utility of the loop 5 epitope in Lyme disease vaccine development publication-title: Clin Vaccine Immunol doi: 10.1128/CVI.00099-06 contributor: fullname: Buckles – volume: 37 start-page: 2137 issue: 7 year: 1999 ident: 10.1016/j.vaccine.2017.04.079_b0060 article-title: Borrelia burgdorferi in tick cell culture modulates expression of outer surface proteins A and C in response to temperature publication-title: J Clin Microbiol doi: 10.1128/JCM.37.7.2137-2141.1999 contributor: fullname: Obonyo – volume: 25 start-page: 466 issue: 3 year: 2007 ident: 10.1016/j.vaccine.2017.04.079_b0125 article-title: Development of an OspC-based tetravalent, recombinant, chimeric vaccinogen that elicits bactericidal antibody against diverse Lyme disease spirochete strains publication-title: Vaccine doi: 10.1016/j.vaccine.2006.07.052 contributor: fullname: Earnhart – volume: 62 start-page: 2037 year: 1994 ident: 10.1016/j.vaccine.2017.04.079_b0255 article-title: A bactericidal antibody to Borrelia burgdorferi is directed against a variable region of the OpsB protein publication-title: Infect Immun doi: 10.1128/IAI.62.5.2037-2045.1994 contributor: fullname: Sadziene – volume: 89 start-page: 5418 issue: 12 year: 1992 ident: 10.1016/j.vaccine.2017.04.079_b0095 article-title: Elimination of Borrelia burgdorferi from vector ticks feeding on OspA-immunized mice publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.89.12.5418 contributor: fullname: Fikrig – volume: 183 start-page: 271 issue: 1 year: 1996 ident: 10.1016/j.vaccine.2017.04.079_b0085 article-title: Borrelia burgdorferi OspA is an arthropod-specific transmission-blocking Lyme disease vaccine publication-title: J Exp Med doi: 10.1084/jem.183.1.271 contributor: fullname: de Silva – volume: 30 start-page: 2830 issue: 11 year: 1992 ident: 10.1016/j.vaccine.2017.04.079_b0285 article-title: Development of polymerase chain reaction primer sets for diagnosis of Lyme disease and for species-specific identification of Lyme disease isolates by 16S rRNA signature nucleotide analysis publication-title: J Clin Microbiol doi: 10.1128/JCM.30.11.2830-2834.1992 contributor: fullname: Marconi – volume: 176 start-page: 4572 issue: 15 year: 1994 ident: 10.1016/j.vaccine.2017.04.079_b0290 article-title: Analysis of the distribution and molecular heterogeneity of the ospD gene among the Lyme disease spirochetes: evidence for lateral gene exchange publication-title: J Bacteriol doi: 10.1128/jb.176.15.4572-4582.1994 contributor: fullname: Marconi – volume: 9 start-page: 1002 issue: 5 year: 2000 ident: 10.1016/j.vaccine.2017.04.079_b0260 article-title: Characterization of an anti-Borrelia burgdorferi OspA conformational epitope by limited proteolysis of monoclonal antibody-bound antigen and mass spectrometric peptide mapping publication-title: Protein Sci doi: 10.1110/ps.9.5.1002 contributor: fullname: Legros – volume: 27 start-page: 146 issue: 4 year: 2005 ident: 10.1016/j.vaccine.2017.04.079_b0010 article-title: Borrelia burgdorferi infections with special reference to horses. A review publication-title: Vet Q doi: 10.1080/01652176.2002.9695196 contributor: fullname: Butler – volume: 75 start-page: 715 issue: 6 year: 2013 ident: 10.1016/j.vaccine.2017.04.079_b0035 article-title: Prevalence of tick borne pathogens in horses from Italy publication-title: J Vet Med Sci doi: 10.1292/jvms.12-0449 contributor: fullname: Laus – volume: 63 start-page: 2221 issue: 6 year: 1995 ident: 10.1016/j.vaccine.2017.04.079_b0250 article-title: Molecular analysis of neutralizing epitopes on outer surface proteins A and B of Borrelia burgdorferi publication-title: Infect Immun doi: 10.1128/IAI.63.6.2221-2227.1995 contributor: fullname: Ma – volume: 67 start-page: 173 issue: 1 year: 1999 ident: 10.1016/j.vaccine.2017.04.079_b0105 article-title: The immunoglobulin (IgG) antibody response to OspA and OspB correlates with severe and prolonged Lyme arthritis and the IgG response to P35 correlates with mild and brief arthritis publication-title: Infect Immun doi: 10.1128/IAI.67.1.173-181.1999 contributor: fullname: Akin – start-page: 467 year: 2010 ident: 10.1016/j.vaccine.2017.04.079_b0115 article-title: Lyme disease vaccines contributor: fullname: Marconi – volume: 25 start-page: 3419 issue: 17 year: 2007 ident: 10.1016/j.vaccine.2017.04.079_b0130 article-title: Construction and analysis of variants of a polyvalent Lyme disease vaccine: approaches for improving the immune response to chimeric vaccinogens publication-title: Vaccine doi: 10.1016/j.vaccine.2006.12.051 contributor: fullname: Earnhart – volume: 198 start-page: 412 issue: 2 year: 2013 ident: 10.1016/j.vaccine.2017.04.079_b0245 article-title: Identification of Borrelia burgdorferi ospC genotypes in canine tissue following tick infestation: implications for Lyme disease vaccine and diagnostic assay design publication-title: Vet J doi: 10.1016/j.tvjl.2013.07.019 contributor: fullname: Rhodes – volume: 26 start-page: 213 issue: 4 year: 2010 ident: 10.1016/j.vaccine.2017.04.079_b0005 article-title: Lyme borreliosis in dogs and humans in the USA publication-title: Trends Parasitol doi: 10.1016/j.pt.2010.01.006 contributor: fullname: Little – volume: 18 start-page: 901 issue: 6 year: 2011 ident: 10.1016/j.vaccine.2017.04.079_b0240 article-title: Disulfide-mediated oligomer formation in Borrelia burgdorferi outer surface protein C, a critical virulence factor and potential Lyme disease vaccine candidate publication-title: Clin Vaccine Immunol doi: 10.1128/CVI.05004-11 contributor: fullname: Earnhart |
SSID | ssj0005319 |
Score | 2.394812 |
Snippet | Abstract The lipoprotein OspA is produced by the Lyme disease spirochetes primarily in unfed ticks. OspA production is down-regulated by the blood meal and it... The lipoprotein OspA is produced by the Lyme disease spirochetes primarily in unfed ticks. OspA production is down-regulated by the blood meal and it is not... |
SourceID | pubmedcentral proquest crossref pubmed elsevier |
SourceType | Open Access Repository Aggregation Database Index Database Publisher |
StartPage | 3178 |
SubjectTerms | Allergy and Immunology Amino acids Animals Antibodies Antibodies, Bacterial - blood Antigens, Bacterial - immunology Antigens, Surface - chemistry Antigens, Surface - genetics Antigens, Surface - immunology Arachnids Arthritis Autoimmunity Bacterial Outer Membrane Proteins - chemistry Bacterial Outer Membrane Proteins - genetics Bacterial Outer Membrane Proteins - immunology Bacterial Vaccines - chemistry Bacterial Vaccines - genetics Bacterial Vaccines - immunology Bactericidal activity Borrelia burgdorferi - chemistry Borrelia burgdorferi - genetics Borrelia burgdorferi - growth & development Borrelia burgdorferi - immunology Chimeritope Drug Discovery Epitopes Epitopes - chemistry Epitopes - immunology Feeding Immunization Immunogenicity Immunoglobulin G - blood Immunoglobulins Immunology Integration Ixodes - microbiology Ixodes ticks LFA-1 antigen Lipoproteins - chemistry Lipoproteins - genetics Lipoproteins - immunology Lyme disease Lyme Disease - prevention & control Lyme Disease Vaccines - immunology Lyme vaccine Mammals Markets Mice Midgut OspA protein OspC Outer surface protein A Peptides - administration & dosage Peptides - chemistry Peptides - immunology Polymerase Chain Reaction Proteins Residues Serum Bactericidal Antibody Assay Spirochetes Ticks Vaccination Vaccine development Vaccines Vaccines, Subunit - administration & dosage Vaccines, Subunit - immunology VANGUARDcrLyme Vector-borne diseases |
SummonAdditionalLinks | – databaseName: ProQuest Public Health Database dbid: 8C1 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV3db9MwELdgCMQLgvJVGOiQ0J6WLYmdJuEFTRPTQAwmsaG-Wf64iE6QlqZD6p_Ff8hd4rQdIHitbTmuz3c_-353J8RLsuq5LSoT5TL1kTKFiWyaVJFTVpaVQ4PI7x0nH0bH5-rdOBuHB7cm0Cp7ndgqaj91_Ea-z4ZLFgT389ez7xFXjWLvaiihcV3cSEgwuXRDcbhB8ZBtYQ-6ZqhIJfF4HcGzf7H3wzh2XTO7K2-znTKb6--26U_s-TuFcsMmHd0VdwKYhINu9--Ja1gPxM2uvORyIG6dBMf5QOycdimql7twto64anZhB07XyatpzOAz82PaIF3oh98XP7t43io88MG0AgMeK2r0wEDVzAFnpBxmCJMaCFTCx2Z2AG0WiEnbn397v_yGEFxCwC5-LtdFWJcazQLwK822aMB2CaTdxNPaaOMnduqXMO_IvNi8grcbLHgg0A3hTwa_ZkA9EOdHb84Oj6NQ7CFydElaRF7KGDNflA5daV1WGgKuUrocR3mFlTM2iau0zKzMlEefxsp5SZfTxHurYqvkQ7FVT2t8LMCkFfoykwQfrbJZak3BMDVNMTfSmXQo9vpt1rMup4fuyW4XOnyyZrnQsdIkF0OR98Kg-4BVUrHYhPPe6EQ3qY71p7jFl_E4IcWZFXE-FMVqZIA0HVTRZLH-N-l2L3Z6Pc_qFAzFi1UzaQR285gap5fUpyhHKuESKkPxqJPS1TIZjNAFXdGKrsjvqgNnG7_aUk--tFnHCSoS4kme_PuznorbvIaOX7EtthbzS3xGsG1hn7dn8xcJLUgL priority: 102 providerName: ProQuest |
Title | Identification of a defined linear epitope in the OspA protein of the Lyme disease spirochetes that elicits bactericidal antibody responses: Implications for vaccine development |
URI | https://www.clinicalkey.es/playcontent/1-s2.0-S0264410X17305807 https://dx.doi.org/10.1016/j.vaccine.2017.04.079 https://www.ncbi.nlm.nih.gov/pubmed/28479174 https://www.proquest.com/docview/1901386197 https://search.proquest.com/docview/1896414278 https://pubmed.ncbi.nlm.nih.gov/PMC8203411 |
Volume | 35 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELdGJxAvCMpXYaBDQnta2iR2moS3Um3qgJUKNtQ3y18RmSCtmg6pL_xP_Iec46RZGRISL2kb23WcnO9-zv3uTMhrtOqxTDLhxTTUHhOJ8GQYZJ5ikqaZMsIY-77jbDqcXLB382i-R8ZNLIylVda63-n0SlvXZwb13Rws83zw2a9suT8PUEijxEaU76M5YqxD9ken7yfTlulBq_09bH3PNmgDeQaX_R9CWQ-2JXnFVdJTS-r6u4m6CUH_ZFJeM00n98m9GlPCyF32A7Jnii657XaZ3HTJnbPaf94lhzOXqXpzBOdt4FV5BIcwa3NYY5vuF0uTqWJ1oWn-kPxyYb1Z_Z4PFhkI0CbDQg0Wr4oVmCXqiKWBvADElvCxXI6gSgaRV_XtuQ-b7wZqzxBYT7_dtQshLxaKNZhv2Nu6BOnySKtc49jw-edyoTewcpxeU76B02tkeEDsDfVNBt0SoR6Ri5Pj8_HEq_d88BSuldaeptQ3kU5SZVQqVZQKxK-UqtgM48xkSsjAz8I0kjRi2ujQZ0pTXKMGWkvmS0Yfk06xKMxTAiLMjE4jiihSMhmFUiQWrYahiQVVIuyRfvOY-dKl9uAN5-2S15fMrVxwn3GUix6JG2HgTdwqalpT1tO-5AEvQ-7zG6LZI8m25Y50czRc_-r0oBE73vaTWgczrn3xn19ti1ExWG-PKMziCusk6RCnQxgnPfLESel2mBaT4Dqd4Yh25HdbwSYd3y0p8q9V8nFEjAh8gmf_P6Ln5K795SgYB6SzXl2ZF4js1vIludX_GeAxnsd4TMb43c1l_Hx7PJ19-g21xlgS |
link.rule.ids | 230,315,786,790,891,4521,12083,12250,21416,24144,27955,27956,31752,31753,33299,33300,33777,33778,43343,43612,43838,45618,45712,74100,74369,74657 |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV3db9MwELdgiI8XBIVBYMAhoT0tWxI7dcILmhBTB-2YRIf6ZvkrohOkpcmQ-mfxH3JOnGYDBK-1Lcf1-e5n3-_uCHmFVp2rrJAhp4kJmcxkqJK4CDVTNC-0lda6947JyXB0xt7P0pl_cKs8rbLTiY2iNgvt3sgPnOGiGcJ9_mb5PXRVo5x31ZfQuE5uMEqZk3M-4z3FgzaFPfCawUIWR7M-gufgfP-H1M517dhdvMl26thcf7dNf2LP3ymUl2zS0T1y14NJOGx3_z65ZssBudmWl1wPyK2Jd5wPyO5pm6J6vQfTPuKq2oNdOO2TV-OYwWfHj2mCdKEb_oD8bON5C__AB4sCJBhbYKMBB1TlCuwSlcPSwrwEBJXwsVoeQpMFYt70d7-N198seJcQOBe_K9eFWBcbZQ32K85WV6DaBNJ6bnBtuPFztTBrWLVkXlu9huNLLHhA0A3-TwbTM6AekrOjd9O3o9AXewg1XpLq0FAa2dRkubY6VzrNJQJXSjW3Q17YQksVR0WSp4qmzFiTREwbipfT2BjFIsXoNtkqF6V9TEAmhTV5ShE-KqbSRMnMwdQksVxSLZOA7HfbLJZtTg_Rkd3Ohf9k4eRCREygXASEd8IguoBVVLG28ue9ErGoEhGJT1GDL6NZjIozzSIekGwz0kOaFqoItFj_m3SnEzvRz7M5BQF5uWlGjeDcPLK0iwvsk-VDFrsSKgF51ErpZpkOjOAFneGKrsjvpoPLNn61pZx_abKOI1RExBM_-fdnvSC3R9PJWIyPTz48JXfcelquxQ7ZqlcX9hlCuFo9b87pLwYeSzA |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV3fb9MwELZgiIkXBAVGYcAhoT0taxI7TcILmgbVBtuoxIb6Zvmn6MSSrumQ-mfxH3JOnKYDBK-xLcfJ-e6z77s7Qt6gVU9lZkWQ0lgHTGQikHFkA8Ukza0ywhh333FyOjw8Zx8nycTznypPq2x1Yq2odancHfnAGS6aIdxPB9bTIsbvR-9mV4GrIOU8rb6cxm1yB63i0El4drBG96B1kQ88crCAReGki-YZXOz9EMq5sR3TK60znzpm19_t1J849Hc65Zp9Gj0g9z2whP1GEh6SW6bokbtNqcllj2yeeCd6j-yMm3TVy10466Kvql3YgXGXyBrH9L46rkwdsAvt8EfkZxPba_1lH5QWBGhjsVGDA61iDmaGimJmYFoAAkz4XM32oc4IMa37u2fHy0sD3j0Ezt3vSnch7sVGsQDzHWdbVCCbZNJqqnFtKARTWeolzBtir6newtEaIx4QgIP_yKA7NtRjcj76cHZwGPjCD4HCA9Mi0JSGJtFZrozKpUpygSCWUpWaYWqNVUJGoY3zRNKEaaPjkClN8aAaaS1ZKBl9QjaKsjBPCYjYGp0nFKGkZDKJpcgcZI1jkwqqRNwne-1v5rMmvwdviW8X3L8yd3LBQ8ZRLvokbYWBt8GrqG5N5fd-xSNexTzkX8Iaa4aTCJVokoVpn2SrkR7eNLCFo_X636Tbrdjxbp7VjuiT16tm1A7O5SMKU15jnywfssiVU-mTrUZKV8t0wAQP6wxXdEN-Vx1c5vGbLcX0W52BHGEjop_o2b9f6xXZxC3Kj49OPz0n99xyGtrFNtlYzK_NC0RzC_my3qa_ACpjTzk |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Identification+of+a+defined+linear+epitope+in+the+OspA+protein+of+the+Lyme+disease+spirochetes+that+elicits+bactericidal+antibody+responses%3A+Implications+for+vaccine+development&rft.jtitle=Vaccine&rft.au=Izac%2C+Jerilyn+R&rft.au=Oliver%2C+Jr%2C+Lee+D&rft.au=Earnhart%2C+Christopher+G&rft.au=Marconi%2C+Richard+T&rft.date=2017-05-31&rft.eissn=1873-2518&rft.volume=35&rft.issue=24&rft.spage=3178&rft_id=info:doi/10.1016%2Fj.vaccine.2017.04.079&rft_id=info%3Apmid%2F28479174&rft.externalDocID=28479174 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0264-410X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0264-410X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0264-410X&client=summon |